MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT04604587

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04604587
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04604587. Allocation not applicable; no masking; primary purpose diagnostic. Start 2020-10-08 (actual); primary completion 2023-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
Acronym
CAA
Condition
Cerebral Amyloid Angiopathy
Condition
Intracerebral Hemorrhage
Intervention (Drug)
1. amyloid PET;2. T807 PET
Lead sponsor
National Taiwan University Hospital (class: other)

Record details

Record id
cardio:ct-nct04604587
Content hash
7038779d351f23e3d098638357006b513e1ed5e2e5f2a3863faaff2a61d5e88f